Updated May 2021:
Dalrada Financial was a defunct organization*** up until January 2018 when out of the blue it began filing again with OTCMarkets.com (up to date). At this point the market got excited and repriced shares from the low .00s up to the .02 range (give or take a penny), where it sat for a solid year with a slow sprinkling of company updates periodically. Ever since that breakout event in January 2018 the stock has exploded to almost $0.50 a share, 14 year high, where it is currently basing for another leg up. Despite having little interest from traders since the initial explosive blip in early 2018, the stock has held its gains amazingly well. We've seen nearly 3 years of updates now as the company went from defunct to having multiple subsidiaries under it's umbrella, multiple acquisitions (very favorable terms for relatively small amounts of restricted common shares, mind you), filing with the SEC(!), and numerous fundamental catalysts on deck (see below press releases). $DFCO is grossly mispriced, but that will change in a hurry when the switch is flipped here. They recently reported a 3,181% Increase In Quarterly Financial Results! Check out what this sleeping giant is up to.
DALRADA FINANCIAL “DFCO”
Publicly-traded on the OTCQB under the symbol “DFCO”, Dalrada and its subsidiaries are positioned for stable long-term growth through intelligent market research, sound business acumen, and established operational infrastructure. The team is dedicated to scaling and accelerating business growth through exceptional financial planning, risk and business analysis, advanced technology platforms, branding, sales and marketing, human resources, legal, accounting, and administrative support.
Dalrada solves real-world problems by producing innovation-focused and technologically-centered solutions on a global level.
Delivering next-generation manufacturing and healthcare products and services that provide and propel growth, Dalrada is a team of industry experts and an organization built upon a strong foundation of financial capital.
OUR BUSINESSES (3 VERTICLES):
Dalrada Precision provides alternative solutions to OEMs through design and manufacturing of component parts that are customized for any specific solution.
The company also produces heater/chiller units that provide simultaneous heating and cooling, without the need for combustion or the burning of fossil fuels, through its wholly-owned company, Likido.
Through its technology division, Prakat Solutions, the company brings over 10 years of expertise providing end to end product engineering services across various domains, including – Banking & Financial Services, Telecom, Retail, Healthcare, Manufacturing, Legal and IT Infrastructure.
DALRADA HEALTH PRODUCTS
Dalrada Health is in the business of solving health problems – globally. The company develops products and services that address the unmet needs of consumers due to accessibility, affordability, or availability. With operations in the U.S., Malaysia, and India, Dalrada Health is able to reach underserved markets through strong partnerships and the development of efficient supply chains.
NEWS/PRESS RELEASE HISTORY:
RECENT PRESS RELEASE HIGHLIGHTS:
Dalrada Financial Corporation Announces Up List To OTCQB Market
Dalrada Reports 3,181% Increase In Quarterly Financial Results
Dalrada Financial Corp Records First Sales of LikidoVOLT® Independent Power Generators With Hidden Villa Ranch
Prakat and Dragonchain Partner to Create Clean Energy, Fintech, and Healthcare Blockchain Solutions
Dalrada Launches Development of Likido®HOME Water Heater Designed to Improve Energy Efficiency by 300% and Significantly Reduce Carbon Emissions
Dalrada Financial Corporation Launches LikidoVOLT® Independent Power Generators With 90% Clean Energy Efficiency Range
Dalrada Executes Contract For Likido North America Exclusive Manufacturing With Tongrun International
Dalrada Precision Acquires Green Energy License For 87% Energy Efficiency And Cost-Savings Advancing Subsidiary Abilities
DFCO'S Likido Limited Awarded Clean Energy Grant By Innovate UK, Aligns With CLIMAGAL S.L. For Europe Climate Change Implementation
Dalrada Health Presents VIA Cervical Cancer Screening Study Findings at 17th World Congress for Cervical Pathology and Colposcopy
Dalrada Financial Corporation Aids COVID-19 Vaccination Administration With Healthcare Staff Of Newly Acquired International Healthcare Group (IHG)